Vimian Group AB (publ) (STO:VIMIAN)
34.35
+0.25 (0.73%)
Jul 28, 2026, 3:03 PM CET
Vimian Group AB Financials Overview
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 450.9 | 428.4 | 378.6 | 331.8 | 281.31 | 173.35 |
Revenue Growth | 11.53% | 13.15% | 14.11% | 17.95% | 62.28% | 143.37% |
Gross Profit Gross Profit Growth | 310.3 | 296.2 | 262.1 | 229.5 | 193.99 | 122.85 |
Operating Income Operating Income Growth | 80.2 | 66.8 | 49.2 | 41.3 | 39.36 | 21.6 |
Net Income Net Income Growth | 36.8 | 31.3 | 18.5 | 9.8 | -6.74 | 6.59 |
Earnings Per Share EPS Growth | 0.07 | 0.06 | 0.04 | 0.02 | -0.02 | 0.02 |
EPS Growth | 40.00% | 50.00% | 100.00% | - | - | -88.89% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Medtech Medtech Growth | 164.5 | 155.5 | 123.9 | 113.6 | 101.44 | 61.94 |
Veterinary Services Veterinary Services Growth | 69.7 | 64.5 | 58.2 | 49.5 | 34.35 | 16.83 |
Diagnostics Diagnostics Growth | 26 | 22.9 | 20.9 | 21.5 | 23.14 | 26.66 |
Specialty Pharma Specialty Pharma Growth | 190.9 | 182.4 | 172 | 147.4 | 124.22 | 68.45 |
Eliminations Eliminations Growth | -0.3 | -0.4 | -0.3 | -0.2 | -1.83 | -0.53 |
Total Total Growth | 450.8 | 424.9 | 374.7 | 331.8 | 281.31 | 173.35 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 51.6 | 55 | 64.8 | 37.5 | 42.19 | 55.11 |
Total Debt Total Debt Growth | 278.8 | 238.7 | 233.6 | 313.8 | 220.96 | 180.37 |
Net Cash (Debt) Net Cash Growth | -227.2 | -183.7 | -168.8 | -276.3 | -178.76 | -125.25 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.43 | -0.35 | -0.33 | -0.61 | -0.44 | -0.36 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 93.3 | 105.7 | 58.1 | -28.6 | 25.31 | 16.01 |
Capital Expenditures CapEx Growth | -12 | -9.1 | -6.3 | -7.9 | -5.82 | -5.41 |
Free Cash Flow Free Cash Flow Growth | 81.3 | 96.6 | 51.8 | -36.5 | 19.49 | 10.61 |
Free Cash Flow Growth | 11.29% | 86.49% | - | - | 83.76% | 1549.61% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 68.82% | 69.14% | 69.23% | 69.17% | 68.96% | 70.87% |
Operating Margin | 17.79% | 15.59% | 13.00% | 12.45% | 13.99% | 12.46% |
Pretax Margin | 12.09% | 10.71% | 7.63% | 5.85% | 0.33% | 7.36% |
Profit Margin | 8.41% | 7.54% | 5.10% | 3.16% | -2.56% | 4.48% |
FCF Margin | 18.03% | 22.55% | 13.68% | -11.00% | 6.93% | 6.12% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 44.22 | 46.80 | 86.70 | 128.69 | - | 374.91 |
Forward PE | 25.60 | 23.76 | 32.40 | 28.67 | 21.95 | 69.93 |
P/FCF Ratio | 20.09 | 15.32 | 35.07 | - | 53.34 | 275.27 |
PS Ratio | 3.62 | 3.45 | 4.80 | 3.55 | 3.70 | 16.84 |